Re-epithelialization acceleration

Re-epithelialization acceleration is not a single molecular target but rather a complex biological process and therapeutic goal within the field of wound healing and regenerative medicine. It involves the resurfacing of a wound with a new epithelium, primarily driven by the migration, proliferation, and differentiation of keratinocytes from the wound edges and dermal appendages. This process is orchestrated by a variety of growth factors, cytokines, and extracellular matrix components, including Epidermal Growth Factor (EGF), Keratinocyte Growth Factor (KGF), and Transforming Growth Factor-beta (TGF-β). In clinical contexts, accelerating this process is critical for treating chronic wounds like diabetic ulcers, as delayed re-epithelialization increases the risk of infection and tissue necrosis. Therapeutic interventions aimed at this process typically target specific receptors such as the EGFR or involve the application of bio-engineered skin substitutes and growth factor topicals.

Other names

Wound re-epithelializationEpithelial regenerationKeratinocyte migration and proliferationWound closure acceleration

Stimulation of keratinocyte migration, proliferation, and differentiation through the activation of growth factor signaling pathways (e.g., EGFR, FGFR).